ClinicalTrials.gg
Sign In
Status unknownNCT05987085WLPFDUpdated Nov 21, 2023

Medical Weight Loss on Pelvic Floor Dysfunction

An observational study in Weight Loss and Pelvic Floor Disorders, sponsored by Peking Union Medical College Hospital. Status unknown at 1 site in China. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-21.

Sponsored by Peking Union Medical College Hospital · Observational

The sponsor has not verified this record recently (last verified Aug 2023), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
200
Ages
18 Years and older
Sex
Female
01

Study summary

The goal of this observational study is to learn about the effect of medical weight loss on the symptom of pelvic floor dysfunction in obese and overweight women. The main question it aims to answer is: whether medical weight loss improves symptoms of pelvic floor dysfunctions in obese or overweight women.

02

Conditions studied

  • Weight Loss
  • Pelvic Floor Disorders
03

In context

Weight Loss

1,818 studies on the registry are indexed under Weight Loss; 286 are open to participants now.

This study's planned enrollment of 200 is above the median of 95 across 226 observational studies indexed under Weight Loss.

Browse Weight Loss studies →

Lead sponsor

Peking Union Medical College Hospital is the lead sponsor of 1,148 studies on the registry; 473 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Browse Peking Union Medical College Hospital studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Adult women seeking medical weight loss

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 or higher
  • BMI 24 kg/m2 or higher
  • Willing to follow the weight loss plan set by the physician follow-up and complete this study

Exclusion criteria

Exclusion Criteria:

  • Urinary tract infection or gynecologic reproductive system infection in the past month
  • Treatment history of pelvic floor disorders
  • Pregnancy or delivery in the past half year
  • Women with severe systemic disease
  • No follow-up conditions
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
200 participants (estimated)
Patient registry
No

Interventions

  • OtherDiet and exercise

    Routine intervention included diet control and exercise

06

What researchers measure

Primary outcomes

  1. Pelvic floor symptoms before and after medical weight loss

    Time frame: At least half a year

Secondary outcomes

  1. To explore the related factors of symptom improvement in pelvic floor dysfunction

    Time frame: At least half a year

  2. To explore the improvement of quality of life before and after medical weight loss

    Time frame: At least half a year

07

Study locations

1 of 1 sites recruiting
  • Peking Union Medical College Hospital
    Beijing, Beijing Municipality 100730, China
    • Zhijing Sun · Contact · sunzhj2001@sina.com · 19800312327
    • Zhao Tian · Principal investigator
    Recruiting
08

References and documents

Publications

  • Tian Z, Chen W, Sun Z. Protocol for a prospective longitudinal cohort study on the effects of non-surgical weight loss on pelvic floor dysfunction. BMJ Open. 2024 Feb 5;14(2):e079143. doi: 10.1136/bmjopen-2023-079143. PubMed 38316600 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2023 (actual). Primary completion is estimated for Dec 2024, 16 months after the start.

Of 91 non-industry observational studies under Weight Loss, half reached primary completion within 38 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 84. This study's planned 16 months is below that.

Counting every sponsor, half of 97 studies reached it within 37 months; a quarter within 16 and three quarters within 84.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 4, 2023
First posted
Aug 14, 2023
StartActual
Aug 3, 2023
Primary completionEst.
Dec 2024
CompletionEst.
Dec 2024
Last update
Nov 21, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 21, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05987085
Lead sponsor
Peking Union Medical College Hospital
Responsible party
Zhijing Sun (Professor, Peking Union Medical College Hospital) — Principal investigator
First posted
Aug 14, 2023
Start date
Aug 3, 2023
Primary completion
Dec 2024 (estimated)
Completion
Dec 2024 (estimated)
Last update
Nov 21, 2023

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Weight Loss →

Other studies from this sponsor

Peking Union Medical College Hospital →

Start the discussion